Reimagining Methadone Clinics: A Case For Integrating Risk Reduction to Address the Complex Realities of Opioid Use...

Area of Science:

• Public Health
• Substance Use Disorders
• Harm Reduction

Background:

• Opioid treatment programs (OTPs) face challenges with compliance-focused frameworks that don't meet patient needs during the opioid crisis.
• OTPs are uniquely positioned to offer risk reduction services like naloxone and safer use supplies.

Purpose of the Study:

• To describe the implementation and early outcomes of integrating safer use kit distribution in a large OTP.
• To assess the feasibility and impact of providing harm reduction tools within an established treatment setting.

Main Methods:

• A pragmatic pilot program workflow was developed for distributing safer use kits in an OTP.
• Patients selected from a menu of kits containing fentanyl/xylazine test strips and safer use supplies.
• Kit distribution was tracked, and patient-facing staff were surveyed post-implementation.

Main Results:

• 643 kits were distributed to 142 unique patients over 13 months.
• Fentanyl/xylazine test strips and safer smoking kits were in high demand.
• Staff reported enhanced patient engagement, reduced stigma, and stronger therapeutic relationships.

Conclusions:

• Integrating safer use kits into OTPs is feasible and impactful, with high patient uptake and positive staff feedback.
• This model shows potential for more inclusive, patient-centered care in addiction treatment.
• Further research is needed to evaluate downstream effects on patient retention and clinical outcomes.